Home/Filings/4/0001213900-22-014562
4//SEC Filing

Lis William 4

Accession 0001213900-22-014562

CIK 0001788028other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 6:01 PM ET

Size

12.5 KB

Accession

0001213900-22-014562

Insider Transaction Report

Form 4
Period: 2022-03-21
Lis William
DirectorChief Executive Officer
Transactions
  • Award

    Voting Common Stock

    2022-03-21+89,97289,972 total
  • Award

    Stock Option (right to buy)

    2022-03-21+7,5007,500 total
    Exercise: $3.54Exp: 2032-03-21Voting Common Stock (7,500 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-21+89,97289,972 total
    Exercise: $3.54Exp: 2032-03-21Voting Common Stock (89,972 underlying)
  • Award

    Stock Option (right to buy)

    2022-03-21+100,000100,000 total
    Exercise: $3.54Exp: 2032-03-21Voting Common Stock (100,000 underlying)
Footnotes (4)
  • [F1]The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of June 24, 2022 and June 27, 2022, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
  • [F2]1/4th of the shares subject to the option shall vest on December 7, 2022, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
  • [F3]1/4th of the shares subject to the option vested on March 21, 2022, and 1/4th of the shares subject to the option shall vest on each of March 24, 2022, September 24, 2022 and March 24, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
  • [F4]1/12th of the shares subject to the option shall vest on April 15, 2022, and 1/12th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001574558

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:01 PM ET
Size
12.5 KB